Bayer AG

Chemicals
Germany
Executive 1Dr. Marijn E. Dekkers, Chairman; Member | Chairman; Member
Executive 2Dr. Kemal Malik, Member; | Senior Vice President;
Earnings Per Share Growth (%)7.25%
Cost of Goods Sold (US$ Millions)$24,633
Current Liabilities (US$ Millions)$18,844
Total Assets (US$ Millions)$27,017
Long Term Debt (Millions)N/A
Return on Equity16.62%
Revenue (US$ Millions)$52,212
Total Company Assets$85,370
Revenue Growth (%)4.63%
Net Income (US$ Millions)$4,185
Earnings Per Share (US$)$5.03
Total Equity (US$ Millions)$24,439
Profit Margin (%)8.02%
Debt To Equity Ratio (%)N/A
Inventories (Millions)$10,305